Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company sponsored by Oaktree Capital Management, dedicated to identifying and combining with businesses in the life sciences sector. Founded in 2021, the company undertook an initial public offering to raise capital for the acquisition of one or more targets engaged in areas such as biotechnology, pharmaceuticals, medical devices, and related healthcare services. As a SPAC, OACC provides a streamlined path for private life sciences companies to access public markets and benefit from Oaktree’s deep industry expertise.
The company’s primary business activity involves sourcing, evaluating, and executing a business combination with high-growth life sciences firms. OACC seeks to partner with companies that possess innovative drug pipelines, novel therapeutic platforms, or cutting-edge medical technologies. Through its public listing, the SPAC offers target companies immediate liquidity, enhanced visibility with institutional and retail investors, and access to a capital structure tailored to support research and development initiatives and commercial expansion.
OACC is backed by Oaktree Capital Management, a global alternative investment manager renowned for its experience in credit, private equity, and real assets. The Oaktree team combines sector-specific knowledge with rigorous due diligence and a disciplined value-oriented approach. Leadership at Oaktree Acquisition Corp. III Life Sciences includes investment professionals who have managed numerous public listings and mergers, supported by the broader Oaktree organization’s resources in strategic advisory, risk management, and operational oversight.
While headquartered in Los Angeles, OACC’s search for acquisition targets spans North America, Europe, and other markets with vibrant life sciences ecosystems. The SPAC’s transaction structure typically involves placing proceeds from its IPO into a trust account until a qualifying business combination is announced. With a dedicated focus on life sciences, Oaktree Acquisition Corp. III Life Sciences aims to facilitate growth for innovative healthcare companies and deliver value to its shareholders by leveraging Oaktree’s established network and investment capabilities.
AI Generated. May Contain Errors.
